Company Description

Renova Therapeutics is working to create a portfolio of gene therapies to restore health to people suffering from cardiovascular and metabolic diseases. The company’s first targets are gene therapies for congestive heart failure (CHF) and type 2 diabetes, two of the most common and devastating chronic diseases in the world.